Latest News and Press Releases

SALT LAKE CITY, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced today that it has filed a registration statement on Form S-1...

2016 Convertible Note amended reducing principal to $36 Million SALT LAKE CITY, Feb. 10, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today...

SALT LAKE CITY, Feb. 03, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced the Journal of Clinical Microbiology published results...

SALT LAKE CITY, Feb. 01, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced the completion of the clinical trial and 510(k)...

SALT LAKE CITY, Jan. 26, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced today that its stock will again trade under the symbol GBSN...

Quarterly revenue growth of 15.8% quarter-over-quarter and 39.2% year-over-year;Company’s New Business Funnel of active evaluations and scheduled evaluations reaches $2.54 million in potential new...

SALT LAKE CITY, Jan. 20, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSND), a molecular diagnostics company, announced today that it has submitted a request to the Securities and...

SALT LAKE CITY, Dec. 28, 2016 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSND), a molecular diagnostics company, announced today that its stock is currently trading under a temporary...

SALT LAKE CITY, Dec. 28, 2016 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSND), a molecular diagnostics company, announced today that it has effected a 1:300 reverse split of its...

SALT LAKE CITY, Dec. 22, 2016 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced that during a special meeting of stockholders held today,...